X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (412) 412
Publication (44) 44
Newsletter (39) 39
Book Review (8) 8
Conference Proceeding (6) 6
Magazine Article (4) 4
Newspaper Article (4) 4
Book Chapter (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ranolazine (444) 444
humans (218) 218
index medicus (214) 214
cardiac & cardiovascular systems (141) 141
male (139) 139
animals (128) 128
female (112) 112
piperazines - administration & dosage (100) 100
piperazines - therapeutic use (97) 97
pharmacology & pharmacy (92) 92
angina pectoris (87) 87
treatment outcome (83) 83
drug therapy (80) 80
dosage and administration (77) 77
acetanilides - administration & dosage (75) 75
angina pectoris - drug therapy (70) 70
research (69) 69
acetanilides - therapeutic use (68) 68
middle aged (68) 68
atrial fibrillation (67) 67
aged (61) 61
antianginal agent (59) 59
care and treatment (59) 59
piperazines - pharmacology (58) 58
electrocardiography (56) 56
ischemia (55) 55
analysis (54) 54
acetanilides - pharmacology (51) 51
late sodium current (50) 50
atrial fibrillation - drug therapy (48) 48
cardiovascular (46) 46
heart (46) 46
acetanilides (45) 45
enzyme inhibitors - administration & dosage (45) 45
angina (44) 44
dose-response relationship, drug (44) 44
enzyme inhibitors - therapeutic use (42) 42
arrhythmias (38) 38
piperazines - adverse effects (38) 38
anti-arrhythmia agents - administration & dosage (34) 34
disease models, animal (34) 34
drug therapy, combination (34) 34
double-blind method (33) 33
drugs (32) 32
exercise tolerance (32) 32
atrial fibrillation - physiopathology (31) 31
acetanilides - adverse effects (30) 30
amiodarone (30) 30
article (30) 30
cardiology (29) 29
chronic disease (29) 29
heart failure (29) 29
heart rate - drug effects (29) 29
randomized controlled-trial (29) 29
rats (29) 29
time factors (28) 28
anti-arrhythmia agents - therapeutic use (27) 27
cardiovascular disease (27) 27
pharmacology (27) 27
abridged index medicus (26) 26
adult (26) 26
chronic angina (26) 26
risk factors (26) 26
usage (26) 26
arrhythmia (25) 25
randomized controlled trials as topic (25) 25
sodium channel blockers - pharmacology (25) 25
cardiac arrhythmia (24) 24
cardiovascular agents - therapeutic use (24) 24
ranolazine - administration & dosage (24) 24
sodium channel blockers - therapeutic use (24) 24
administration, oral (23) 23
amlodipine (23) 23
cardiovascular agents - administration & dosage (23) 23
diabetes (23) 23
drug administration schedule (23) 23
heart attacks (23) 23
inhibition (23) 23
follow-up studies (22) 22
medical research (22) 22
myocardial ischemia - drug therapy (22) 22
physiological aspects (22) 22
piperazines - pharmacokinetics (22) 22
rabbits (22) 22
sodium channel blockers - administration & dosage (22) 22
acute coronary syndromes (21) 21
biological products industry (21) 21
chronic stable angina (21) 21
clinical trials (21) 21
coronary artery disease (21) 21
peripheral vascular disease (21) 21
repolarization (21) 21
sodium-channel block (21) 21
action potentials - drug effects (20) 20
angina, stable - drug therapy (20) 20
coronary heart disease (20) 20
dogs (20) 20
efficacy (20) 20
health aspects (20) 20
sodium (20) 20
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (452) 452
Chinese (2) 2
Russian (2) 2
Danish (1) 1
German (1) 1
Italian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drug Safety, ISSN 0114-5916, 6/2012, Volume 35, Issue 6, pp. 459 - 470
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2012, Volume 110, Issue 5, pp. 673 - 677
Journal Article
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 11/2018, Volume 58, Issue 11, pp. 1436 - 1442
The antianginal agent ranolazine (Ranexa®) is metabolized primarily by cytochrome P450‐3A (CYP3A) enzymes. Coadministration with strong CYP3A inhibitors, such... 
posaconazole | CYP3A | ranolazine | QT prolongation | drug‐drug interaction | obesity | drug-drug interaction | HUMANS | ADULTS | DISPOSITION | THERAPY | PHARMACOKINETICS | METABOLISM | PHARMACOLOGY & PHARMACY | UPDATE | WEIGHT | Cytochrome | Obesity | Ketoconazole | Cytochrome P450 | Drug interactions | Patients | Recovery | Weight | Body mass index | Body mass | Body size | Drug interaction | Posaconazole | Prolongation | Cytochromes P450
Journal Article
European Heart Journal, ISSN 0195-668X, 05/2016, Volume 37, Issue 19, pp. 1504 - 1513
Journal Article
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2013, Volume 165, Issue 6, pp. 854 - 861.e2
Journal Article
Journal Article
Journal of Cardiovascular Pharmacology, ISSN 0160-2446, 06/2011, Volume 57, Issue 6, pp. 639 - 647
Effects of ranolazine alone and in the presence of phenylephrine (PE) or isoproterenol (ISO) on hemodynamics, coronary blood flow and heart rate (HR) in the... 
conscious dogs | ranolazine | antiadrenergic effect | coronary blood flow | hemodynamics | LATE SODIUM CURRENT | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTIANGINAL AGENT | ISCHEMIA | RANDOMIZED CONTROLLED-TRIAL | ACUTE-CORONARY-SYNDROME | INHIBITION | ANGINA | THROMBOLYSIS | PHARMACOLOGY & PHARMACY | Acetanilides - metabolism | Piperazines - administration & dosage | Isoproterenol - toxicity | Adrenergic Antagonists - metabolism | Acetanilides - administration & dosage | Isoproterenol - administration & dosage | Hypertension - drug therapy | Piperazines - metabolism | Vasoconstrictor Agents - toxicity | Ganglionic Blockers - pharmacology | Phenylephrine - administration & dosage | Ranolazine | Dose-Response Relationship, Drug | Heart Rate - drug effects | Hexamethonium - pharmacology | Hypotension - drug therapy | Adrenergic Antagonists - therapeutic use | Hypertension - chemically induced | Acetanilides - therapeutic use | Piperazines - blood | Receptors, Adrenergic, beta - metabolism | Receptors, Adrenergic, alpha - metabolism | Receptors, Adrenergic, beta - chemistry | Vasoconstrictor Agents - administration & dosage | Guinea Pigs | Phenylephrine - toxicity | Adrenergic Antagonists - administration & dosage | Rats | Piperazines - therapeutic use | Receptors, Adrenergic, alpha - chemistry | Autonomic Agents - therapeutic use | Hypotension - chemically induced | Autonomic Agents - administration & dosage | Animals | Vasodilator Agents - toxicity | Adrenergic Antagonists - blood | Dogs | Acetanilides - blood | Hemodynamics - drug effects | Coronary Circulation - drug effects | Kinetics | Vasodilator Agents - administration & dosage
Journal Article
Journal Article
Journal Article
Journal Article